Strange P - Search Results

1

How to investigate and analyse clinical incidents: clinical risk unit and association of litigation and risk management protocol.

Vincent C, Taylor-Adams S, Chapman EJ, Hewett D, Prior S, Strange P, Tizzard A. Vincent C, et al. Among authors: strange p. BMJ. 2000 Mar 18;320(7237):777-81. doi: 10.1136/bmj.320.7237.777. BMJ. 2000. PMID: 10720366 Free PMC article. No abstract available.

2

[How to investigate and analyze clinical incidents: a clinical risk protocol in association with litigation and risk management].

Vincent C, Taylor-Adams S, Chapman EJ, Hewett D, Prior S, Strange P, Tizard A. Vincent C, et al. Among authors: strange p. Ann Fr Anesth Reanim. 2002 Jun;21(6):509-16. doi: 10.1016/s0750-7658(02)00671-8. Ann Fr Anesth Reanim. 2002. PMID: 12134595 French. No abstract available.

3

Repaglinide versus glyburide: a one-year comparison trial.

Marbury T, Huang WC, Strange P, Lebovitz H. Marbury T, et al. Among authors: strange p. Diabetes Res Clin Pract. 1999 Mar;43(3):155-66. doi: 10.1016/s0168-8227(99)00002-9. Diabetes Res Clin Pract. 1999. PMID: 10369424 Clinical Trial.

4

Efficacy and safety of ETC-1002, a novel investigational low-density lipoprotein-cholesterol-lowering therapy for the treatment of patients with hypercholesterolemia and type 2 diabetes mellitus.

Gutierrez MJ, Rosenberg NL, Macdougall DE, Hanselman JC, Margulies JR, Strange P, Milad MA, McBride SJ, Newton RS. Gutierrez MJ, et al. Among authors: strange p. Arterioscler Thromb Vasc Biol. 2014 Mar;34(3):676-83. doi: 10.1161/ATVBAHA.113.302677. Epub 2014 Jan 2. Arterioscler Thromb Vasc Biol. 2014. PMID: 24385236 Clinical Trial.

5

Effects of Dapagliflozin on 24-Hour Glycemic Control in Patients with Type 2 Diabetes: A Randomized Controlled Trial.

Henry RR, Strange P, Zhou R, Pettus J, Shi L, Zhuplatov SB, Mansfield T, Klein D, Katz A. Henry RR, et al. Among authors: strange p. Diabetes Technol Ther. 2018 Nov;20(11):715-724. doi: 10.1089/dia.2018.0052. Epub 2018 Sep 14. Diabetes Technol Ther. 2018. PMID: 30222367 Free PMC article. Clinical Trial.

6

Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients.

Rosenstock J, Sugimoto D, Strange P, Stewart JA, Soltes-Rak E, Dailey G. Rosenstock J, et al. Among authors: strange p. Diabetes Care. 2006 Mar;29(3):554-9. doi: 10.2337/diacare.29.03.06.dc05-0695. Diabetes Care. 2006. PMID: 16505505 Clinical Trial.

7

Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial.

Kennedy L, Herman WH, Strange P, Harris A; GOAL AIC Team. Kennedy L, et al. Among authors: strange p. Diabetes Care. 2006 Jan;29(1):1-8. doi: 10.2337/diacare.29.01.06.dc05-1058. Diabetes Care. 2006. PMID: 16373887 Clinical Trial.

8

Insulin 70/30 mix plus metformin versus triple oral therapy in the treatment of type 2 diabetes after failure of two oral drugs: efficacy, safety, and cost analysis.

Schwartz S, Sievers R, Strange P, Lyness WH, Hollander P; INS-2061 Study Team. Schwartz S, et al. Among authors: strange p. Diabetes Care. 2003 Aug;26(8):2238-43. doi: 10.2337/diacare.26.8.2238. Diabetes Care. 2003. PMID: 12882842 Clinical Trial.

9

Switch to multiple daily injections with insulin glargine and insulin lispro from continuous subcutaneous insulin infusion with insulin lispro: a randomized, open-label study using a continuous glucose monitoring system.

Bode BW, Steed RD, Schleusener DS, Strange P. Bode BW, et al. Among authors: strange p. Endocr Pract. 2005 May-Jun;11(3):157-64. doi: 10.4158/EP.11.3.157. Endocr Pract. 2005. PMID: 16239201 Clinical Trial.

10

TheV-Go insulin delivery device used in clinical practice: patient perception and retrospective analysis of glycemic control.

Rosenfeld CR, Bohannon NJ, Bode B, Kelman AS, Mintz SN, Schorr AB, Sandberg MI, Nambi S, Agarwala SK, Leichter SB, Larrabee B, Shi L, Strange P. Rosenfeld CR, et al. Among authors: strange p. Endocr Pract. 2012 Sep-Oct;18(5):660-7. doi: 10.4158/EP11362.OR. Endocr Pract. 2012. PMID: 22548944

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results